No, MIN-117 is a depression drug while MIN-101 is the schizo drug. MIN-101 stands out because the PANNS data shows an effect on the negative symptoms and on the positive symptoms. Jefferies presentation tomorrow may spell out the effect better and hopefully address the short patent life (2021) on both drugs.
Yes and I think that confused a lot of people. I thought the Schizo trial was the more interesting since there is no drug for the negative symptoms of schizophrenia. Would have been better to release the data on separate days imo.